Concentration of Receptors With Affinity for Cannabidiol and Cannabinol and the Effect on Chronic Orofacial Pain of Muscle Origin
Condition(s) studied
Investigational drug(s) / intervention(s)
Blood CB1, CB2, TRPV-1 concentration measurement: In each of the patients blood CB1, CB2, TRPV-1 concentration will be measure
Study summary
The main aim of the presented project will be to examine the concentration of selected receptors (CB1, CB2, TRPV-1) showing affinity for binding to cannabidol (CBD) and cannabinol (CBN) in blood samples collected from people with chronic pain in the masticatory muscles and from people without this pain. Moreover, study participants will be examined by a qualified doctor, according to the validated and standardized international DC/TMD protocol (Diagnostic Criteria for Temporomandibular Disorders) and the criteria included in ICOP-1 (International Classification of Orofacial Pain, 1st edition). The nature and duration of pain, psychoemotional state and central sensitization (the phenomenon of increased reactivity of the nervous system to stimuli) will be determined using validated questionnaires. The obtained results will be subjected to statistical analysis in order to check the relationships between the examined parameters.
Eligibility
Primary outcome measure(s)
- Relationship between the concentration of receptors with affinity for Cannabidol and Cannabinol and the risk of occurrence and severity of chronic orofacial pain of muscle origin — May 5, 2024 - December 31, 2024
Each participant will undergo blood test focusing on CB1, CB2, TRPV-1 concentration - Assessment of the occurrence of chronic orofacial pain of muscular origin assessed using the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) protocol. — May 5, 2024 - December 31, 2024
Each patient will undergo DC/TMD protocol-based clinical examination using DC/TMD examination form assessing incidence of pain of masticatory muscles and surrounding structures.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Wroclaw Medical University | Wroclaw | Poland |
More Wroclaw Medical University trials in Poland
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06405646 on ClinicalTrials.gov ↗ ← All trials in Poland